LMR Partners’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
LMR Partners's ABUS Position: Q3 2026 in Review
LMR Partners opened a new position in Arbutus Biopharma (ABUS) in Q3 2026: 2,211,209 shares worth $10.6M. The stake represents 0.03% of the portfolio and ranks #436 among its holdings. This is a return to the name: LMR Partners previously reported a position in ABUS as recently as Q4 2024.
LMR Partners first reported a position in ABUS in Q1 2014 and has held it in 22 quarters since. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- LMR Partners held 2,211,209 shares of Arbutus Biopharma worth $10.6M as of Q3 2026.
- Arbutus Biopharma was a new LMR Partners position in Q3 2026.
- Arbutus Biopharma made up 0.03% of LMR Partners's portfolio in Q3 2026, its #436 holding.
- LMR Partners first reported a position in Arbutus Biopharma in Q1 2014 and has held it in 22 quarters since.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.